CSMYF (COSMOS Pharmaceutical) Cyclically Adjusted Revenue per Share: $0.00 (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CSMYF COSMOS Pharmaceutical Corp CSMYF
93 GF Score
Price $37.06
GF Value $50.48
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is COSMOS Pharmaceutical Cyclically Adjusted Revenue per Share?

COSMOS Pharmaceutical CSMYF 93 Cyclically Adjusted Revenue per Share is $0.00 as of Feb. 2026. GuruFocus rates CSMYF with a GF Score™ of 93/100 and a GF Value™ of $50.48 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

COSMOS Pharmaceutical's adjusted revenue per share for the three months ended in Feb. 2026 was $22.225. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Feb. 2026.

During the past 12 months, COSMOS Pharmaceutical's average Cyclically Adjusted Revenue Growth Rate was 10.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 11.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of COSMOS Pharmaceutical was 11.80% per year. The lowest was 10.80% per year. And the median was 11.10% per year.

As of today (2026-07-13), COSMOS Pharmaceutical's current stock price is $37.06. COSMOS Pharmaceutical's Cyclically Adjusted Revenue per Share for the quarter that ended in Feb. 2026 was $0.00. COSMOS Pharmaceutical's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of COSMOS Pharmaceutical was 1.69. The lowest was 0.57. And the median was 1.01.


COSMOS Pharmaceutical  (OTCPK:CSMYF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of COSMOS Pharmaceutical was 1.69. The lowest was 0.57. And the median was 1.01.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


COSMOS Pharmaceutical Cyclically Adjusted Revenue per Share Related Terms


COSMOS Pharmaceutical Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for COSMOS Pharmaceutical's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

COSMOS Pharmaceutical Cyclically Adjusted Revenue per Share Chart

COSMOS Pharmaceutical Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 58.10 67.88 50.93 0.00

COSMOS Pharmaceutical Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.93 51.67 63.24 0.00 0.00

COSMOS Pharmaceutical Cyclically Adjusted Revenue per Share Competitor Comparison

For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


COSMOS Pharmaceutical Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where COSMOS Pharmaceutical's Cyclically Adjusted PS Ratio falls into.


CSMYF
93GF Score
COSMOS Pharmaceutical Corp CSMYF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

COSMOS Pharmaceutical Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, COSMOS Pharmaceutical's adjusted Revenue per Share data for the three months ended in Feb. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Feb. 2026 (Change)*Current CPI (Feb. 2026)
=22.225/112.2000*112.2000
=22.225

Current CPI (Feb. 2026) = 112.2000.

COSMOS Pharmaceutical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201605 13.859 98.200 15.835
201608 15.787 97.900 18.093
201611 14.026 98.600 15.961
201702 13.813 98.100 15.798
201705 14.868 98.600 16.919
201708 15.949 98.500 18.167
201711 14.785 99.100 16.739
201802 16.365 99.500 18.454
201805 16.948 99.300 19.150
201808 17.466 99.800 19.636
201811 16.136 100.000 18.105
201902 17.391 99.700 19.571
201905 18.445 100.000 20.695
201908 19.560 100.000 21.946
201911 18.648 100.500 20.819
202002 19.234 100.300 21.516
202005 22.559 100.100 25.286
202008 22.530 100.100 25.253
202011 21.166 99.500 23.868
202102 21.271 99.800 23.914
202105 21.377 99.400 24.130
202108 21.771 99.700 24.501
202111 20.134 100.100 22.568
202202 20.565 100.700 22.914
202205 19.259 101.800 21.227
202208 19.240 102.700 21.020
202211 17.540 103.900 18.941
202302 19.198 104.000 20.712
202305 20.397 105.100 21.775
202308 21.075 105.900 22.329
202311 19.790 106.900 20.771
202402 20.145 106.900 21.144
202405 20.211 108.100 20.978
202408 22.587 109.100 23.229
202411 20.036 110.000 20.437
202502 20.506 110.800 20.765
202505 22.567 111.800 22.648
202508 23.305 112.100 23.326
202511 21.534 113.200 21.344
202602 22.225 112.200 22.225

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.00 mean?
COSMOS Pharmaceutical (CSMYF) has a Cyclically Adjusted Revenue per Share of $0.00 as of Feb. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on COSMOS Pharmaceutical and its competitors.
Is COSMOS Pharmaceutical's Cyclically Adjusted Revenue per Share too high?
COSMOS Pharmaceutical's current Cyclically Adjusted Revenue per Share is $0.00. Overall, COSMOS Pharmaceutical has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Cyclically Adjusted Revenue per Share compare to competitors?
COSMOS Pharmaceutical's Cyclically Adjusted Revenue per Share of $0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on COSMOS Pharmaceutical and its competitors. COSMOS Pharmaceutical's current Cyclically Adjusted Revenue per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, COSMOS Pharmaceutical (CSMYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $50.48, compared to a current price of $37.06 — trading 26.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $0.00. COSMOS Pharmaceutical's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Cyclically Adjusted Revenue per Share is $0.00 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?

Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued. The current stock price of $37.06 is trading 26.6% below its estimated GF Value™ of $50.48. GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.

Key valuation signals for CSMYF:

  • Cyclically Adjusted Revenue per Share: $0.00
  • GF Value™: $50.48 vs. price of $37.06 (26.6% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


COSMOS Pharmaceutical Business Description

Other Exchanges 3349:Japan
Address 10-1 Hakataeki Higashi 2-chome, 4th floor, JR Hakata Station East NS Building S, Hakata-ku, Fukuoka Prefecture, Fukuoka, JPN, 812-0013
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
93GF Score

Get the complete analysis for CSMYF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$37.06
Price
$50.48
GF Value